DBV Technologies Reports Full Year 2013 Topline Financial Results
1/30/2014 8:50:45 AM
BAGNEUX, France, Jan. 30, 2014 (GLOBE NEWSWIRE) -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today its full year 2013 topline and cash position.
Help employers find you! Check out all the jobs and post your resume.
comments powered by